Societies combine to issue recommendations on use of incretin drugs in obesity therapy

Article excerpt

Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding the use of obesity drugs for weight loss treatment. The statement, which is published in The Lancet Diabetes & Endocrinology, is led by Dr. Laurence Dobbie of the Department of Population Health Sciences, King's College London, with an international team of 26 authors.